Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01693263 · ClinicalTrials.gov registry record
Outcome of BCF Access in Hemodialysis Patients
A clinical trial of End Stage Renal Disease (ESRD) and Dialysis, sponsored by University of Chicago.
- Active
- Registry status
- 96
- Enrollment target
- 1
- Study location
NCT01693263 is a study of End Stage Renal Disease (ESRD) and Dialysis that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 96 participants, below the 367-participant average among 10 other End Stage Renal Disease (ESRD) trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01693263, a study of End Stage Renal Disease (ESRD) and Dialysis, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
Dialysis access, which is the connection that allows blood to flow in and out of the body during dialysis sessions, is important to remove wastes and excess fluid for patients with end stage renal disease (ESRD). One method used to access the vein and artery for dialysis is called a brachiocephalic fistula. Patients are being asked to participate in this study because they have endstage renal disease, and their doctor has recommended that they will have brachiocephalic fistula placed for their dialysis access. A common problem seen in patients with a brachiocephalic fistula (BCF) is cephalic arch stenosis (CAS). CAS is a narrowing in the central vein (located in the upper chest). CAS causes problems with the opening of the veins and arteries needed for dialysis. Once someone suffers CAS they may need several radiology procedures as well as surgery to help correct the problem. The BCF may fail once CAS develops. The purpose of the research study is to gather information about the BCF and what is happening inside the vein. The researchers hope to find out what may be the cause of CAS.
Conditions Studied
Interventions
- OTHER brachiocephalic fistula (BCF)
Study Locations (1)
Illinois
- University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2011-10 |
| Est. Completion | 2026-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01693263
The ClinicalTrials.gov registry entry for NCT01693263 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 367-participant average among 10 other End Stage Renal Disease (ESRD) trials with a reported enrollment target (74% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with End Stage Renal Disease (ESRD) appearing as the primary indexed condition, and to 1 intervention - of which brachiocephalic fistula (BCF) is the first listed.
NCT01693263 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01693263 about?
NCT01693263 is a clinical study titled "Outcome of BCF Access in Hemodialysis Patients". Dialysis access, which is the connection that allows blood to flow in and out of the body during dialysis sessions, is important to remove wastes and excess fluid for patients with end stage renal disease (ESRD). One method used to access the vein and artery for dialysis is called a brachiocephalic ...
What is the current status of trial NCT01693263?
This trial is currently active not recruiting. The enrollment target is 96 participants. The study started on 2011-10. Estimated completion is 2026-02.
What conditions does trial NCT01693263 study?
This clinical trial studies the following conditions: End Stage Renal Disease (ESRD), Dialysis, Brachiocephalic Fistula (BCF), Cephalic Arch Stenosis (CAS).
What interventions are being tested in trial NCT01693263?
The interventions under investigation include: brachiocephalic fistula (BCF) (OTHER).
Who is sponsoring clinical trial NCT01693263?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01693263 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease (ESRD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis
RECRUITING · Phase 3
-
EndoForce Post Approval Study
RECRUITING
-
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
RECRUITING · NA
-
A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment
ACTIVE NOT RECRUITING · Phase 1
-
Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure
ACTIVE NOT RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.